Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  BioMarin Pharmaceutical Inc.    BMRN   US09061G1013

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/14/2013 05/15/2013 05/16/2013 05/17/2013 05/20/2013 Date
70.3(c) 67.81(c) 64.5(c) 64.01(c) 63.01 Last
1 702 332 1 863 698 2 813 266 1 459 698 895 442 Volume
+2.11% -3.54% -4.88% -0.76% -1.56% Change
More quotes
Company
BioMarin Pharmaceutical Inc. is a biotechnology firm based in Novato, California. It has offices and facilities in the US, South America, Asia and Europe. BioMarin's core business and research is in enzyme replacement therapies (ERTs). BioMarin is the first company to provide therapeutics for... 
Read more
Sector
Pharmaceuticals - Diversified
Calendar
05/21 | 09:00amPresentation
Surperformance© rating of BioMarin Pharmaceutical In
Trading Rating : Investor Rating :
More about the company
Chart BIOMARIN PHARMACEUTICAL IN
Duration : Period :
BioMarin Pharmaceutical In Technical Analysis Chart | BMRN | US09061G1013 | 4-Traders
Full-screen chart
Financials ($)
Sales 2013 541 M
EBIT 2013 -164 M
Net income 2013 -175 M
Finance 2013 3,28 M
Yield 2013 -
Sales 2014 671 M
EBIT 2014 -95,1 M
Net income 2014 -101 M
Finance 2014 31,8 M
Yield 2014 -
PER 2013 -
PER 2014
EV / Sales 2013 16,4x
EV / Sales 2014 13,2x
Capitalization 8 898 M
More Financials
Latest news on BIOMARIN PHARMACEUTICAL IN
5h ago BIOMARIN PHARMACEUTICAL INC.: Reports Inducement Grants Under NASDAQ Listing Ru..
4d ago BIOMARIN PHARMACEUTICAL INC.: BioMarin Announces BMN-673 Data in Breast and Ova..
05/02 BIOMARIN PHARMACEUTICAL INC.: BioMarin to Present at the Baird Growth Stock Con..
04/25 BIOMARIN PHARMACEUTICAL INC.: BioMarin Announces First Quarter 2013 Financial R..
04/24 BIOMARIN PHARMACEUTICAL INC.: BioMarin Submits Vimizim MAA to EMA for the Treat..
04/18 BIOMARIN PHARMACEUTICAL INC.: Reports Inducement Grants Under NASDAQ Listing Ru..
04/04 BIOMARIN PHARMACEUTICAL INC.: BioMarin to Host First Quarter 2013 Financial Res..
04/01 BIOMARIN PHARMACEUTICAL INC.: BioMarin Submits Vimizim BLA to the U.S. FDA for ..
04/01 BIOMARIN PHARMACEUTICAL INC.: BioMarin Submits CTA for BMN-190 for Batten Disea..
03/25 BIOMARIN PHARMACEUTICAL INC.: BioMarin Completes Additional Partial Exchange of..
03/20DJU.S. HOT STOCK FUTURES: Hot stocks to watch
03/19 BIOMARIN PHARMACEUTICAL INC.: BioMarin to Advance BMN-701 for Pompe Disease to ..
More news
Forum BIOMARIN PHARMACEUTICAL IN
Be the first to post a message on BIOMARIN PHARMACEUTICAL IN
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
BioMarin Pharmaceutical In : Income Statement Evolution
More Financials
EPS Revisions
BioMarin Pharmaceutical In : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Copyright © 2013 Surperformance. All rights reserved.